CCB drugs Flashcards
Non-
dihydropyridine
MOA
CCB
Non-
dihydropyridine
a slow calcium channel blocker that blocks calcium ion influx during depolarization of cardiac and vascular smooth muscle. It decreases peripheral vascular resistance and causes relaxation of the vascular smooth muscle resulting in a decrease of both systolic and diastolic blood pressure
Non-
dihydropyridine
Drug names
- Diltiazem long-acting
* Verapamil sustained-release
Non-
dihydropyridine
indication
• High coronary disease risk (verapamil-trandolapril )
Non-
dihydropyridine
adverse effect
- Bradycardia
- Heart block
- Constipation
- Hypotension
- Peripheral edema
- HA
- Flushing
Non-
dihydropyridine
monitoring
• Heart rate: caution with HR <60
Non-
dihydropyridine
comments
• Use caution in concomitant use with B-blocker heart block
• Potent CYP inhibitors: DDI’s
Contraindication:
• Hypersensitivity
• Sinus node dysfunction/severe sinus bradycardia (w/o pacemaker)
• Atrial fibrillation/flutter
• Severe hypotension (systolic <90mmHg)
• Severe L ventricular dysfunction (EF <40%)
Dihydropyridines
MOA
Inhibits calcium ion from entering the slow channels of vascular smooth muscle and myocardium during depolarization relaxation of coronary vascular smooth muscle and coronary vasodilation
- acts on vascular smooth muscle to produce peripheral arterial vasodilation
Dihydropyridines
drug names
- Amlodipine
- Felodipine
- Isradipine SR
- Nicardipine SR
- Nifedipine long-acting
- Nisoldipine
Dihydropyridines
indication
• First line option
Dihydropyridines
adverse effect
- Gingival hyperplasia
- Reflex tachycardia (SOB)
- Peripheral edema
- Constipation
Dihydropyridines
comment
• Start at low dose in elderly pts